Clinical Trial Update: Safety and Efficacy Study of KAI-9803 to Treat Subjects With ST Elevation Myocardial Infarction [Heart Attack] [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on KAI-9803 for ST-elevation myocardial infarction, assessing safety and efficacy; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• KAI-9803

Snippet

Sponsor: KAI Pharmaceuticals | Conditions: Myocardial Infarction, Cardiovascular Diseases | Phase 2 | Status: COMPLETED